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Abstract
Introduction: Maxillary sinus augmentation is a predictable implant site development technique,
although several local and systemic factors may influence outcomes. The aim of this study was to
evaluate healing patterns and bone remodeling activity following the use of two different graft
mixtures for maxillary sinus augmentation.
Materials and methods: Patients in need of maxillary sinus augmentation were randomly assigned to
two different groups. A graft mixture using a 50% autologous bone (AB) to 50% anorganic bovine
bone (ABB) ratio was used in group 1, while a 20% AB to 80% ABB ratio was utilized for group 2. After
a 6-month healing period, bone core biopsies were harvested for histological, histomorphometrical,
and immunohistochemical analyses.
Results: Twenty-eight subjects participated in this study. No statistically significant differences were found
between groups in regards to vital bone and non-mineralized tissue proportions. Higher number of
osteoid lines (18.05  10.06 in group 1 vs. 9.01  7.53 in group 2; P¼ 0.023) and higher cellularity,
particularly regarding the number of osteocytes (631.85  607.98 in group 1 vs. 219.08  103.26 in group
2; P¼ 0.002), were observed in specimens from group 1. Differences in expression patterns of osteopontin
and tartrate-resistant acid phosphatase were also detected between groups.
Conclusion: AB to ABB ratio appears to influence bone remodeling patterns and cell content following
maxillary sinus augmentation procedures. Similar proportion of vital bone was found in specimens
obtained from both groups. More cellular presence was observed in samples containing higher
proportions of AB.
Since the introduction of maxillary sinus
augmentation as an implant site development
modality (Boyne & James 1980), several modifi-
cations of the lateral approach technique have
been developed (Vercellotti et al. 2001; Lundgren
et al. 2004; Peleg et al. 2004; Soltan & Smiler
2005; Martos Diaz et al. 2007). Likewise, a
variety of materials (i.e. autografts, allografts,
alloplasts, and xenografts) have been applied for
sinus grafting, typically associated with satisfac-
tory clinical outcomes (Wheeler 1997; Wallace &
Froum 2003; Del Fabbro et al. 2004). According
to the current understanding, there is no evidence
supporting the superiority of any particular bone
graft in terms of implant survival or absence of
complications at the recipient site (Browaeys
et al. 2007; Nkenke & Stelzle 2009). In light of
this information, many clinicians have accepted
as a general consensus the concept that maxillary
sinus augmentation is predictable, regardless of
the grafting material used. However, it is impor-
tant to keep in mind that long-term clinical
success relies on the formation of a functional
vital bone–graft complex, which is influenced by
the type of graft used (Watzek et al. 2006).
Autologous bone (AB) and anorganic bovine
bone (ABB) are the biomaterials with the stron-
gest literature support in sinus augmentation. It
is a general belief that AB is the gold standard
bone grafting material, given its unique osteocon-
ductive, osteoinductive, and osteogenic proper-
ties. However, intense bone remodeling leading
to excessive bone resorption may occur when AB
is used as a sole material for sinus augmentation
(Schlegel et al. 2003). In order to prevent this
unfavorable event, its use in combination with a
slowly absorbable material has been proposed
(Yildirim et al. 2001; Hallman et al. 2002b).
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ABB presents a notable slow resorption rate,
being able to remain stable for years (Sartori
et al. 2003; Traini et al. 2007). Furthermore,
ABB possesses remarkable osteoconductivity, as
well as an ability to allow revascularization
(Galindo-Moreno et al. 2010b). Previous studies
have reported the histologic features of bone
samples obtained after the utilization of AB (Hall-
man et al. 2002b), ABB (Ferreira et al. 2009), or
a combination of them (Wallace et al. 2005;
Galindo-Moreno et al. 2007). Interestingly, tis-
sues analyzed present different characteristics
depending on the nature of the grafting material
applied, the proportion of materials used, and the
time of sample harvesting. Therefore, some
critical questions remain unanswered.
Within the limits of our knowledge, there is a
paucity of controlled studies aimed at evaluating
sinus augmentation outcomes at the histological
level, depending on the AB to ABB ratio in a
large series of patients. Hence, the objective of
the present study was to evaluate tissue response
and bone remodeling activity in samples obtained
after using two different graft mixture ratios for
maxillary sinus augmentation.
Material and methods
Study design and subject recruitment
Before subject recruitment, this prospective
clinical trial was reviewed and approved by the
Institutional Review Board of the University
of Granada. The study was conducted according
to the principles of the Helsinki’s declaration
for experimentation involving human subjects
(Schuklenk & Ashcroft 2000).
Totally or partially edentulous patients in need
of maxillary sinus augmentation were screened
and included in the study according to the follow-
ing inclusion criteria: Adult patients (18–85 years
of age) presenting a physical status according
to the American Society of Anesthesiologists of
I or II (http://www.asahq.org/clinical/physical-
status.htm), no uncontrolled systemic disease,
no condition known to alter bone metabolism
(i.e. osteoporosis, diabetes mellitus), O’Leary
plaque score 20% (O’Leary et al. 1972), and
5 mm of remaining bone height based on radio-
graphic measurements over panoramic films
(Wang & Katranji 2008; Rios et al. 2009). Sub-
jects who reported antibiotic intake within
3 months before study initiation, or long-term
use (46 months) of medications known to mod-
ify bone metabolism (such as bisphosphonates
and corticosteroids), women that were pregnant
or attempting to get pregnant at the time of the
screening, and patients that presented untreated
chronic sinus conditions (i.e. cysts, tumors),
sepsis, history of cancer and/or radiation to the
oral cavity, or complications derived from any of
these conditions affecting the sinus area, were
excluded from the study. Patients who reported
smoking 410 cigarettes per day (Levin et al.
2004), and consumers of 410 g of alcohol per
day (Galindo-Moreno et al. 2005) were also
excluded. For the statistical analysis, patients
who reported smoking one or more cigarettes
per day or consuming one or more alcohol-
containing drinks daily were accounted as
smokers and alcohol consumers, respectively.
Patients who met the inclusion and exclusion
criteria were required to read, understand, and
sign an informed consent before the final enroll-
ment in the clinical trial.
Surgical procedures
Patients were requested to take an antibiotic
(Amoxicillin/Clavulanate 875/125 mg t.i.d. for
10 days, starting 2 days before the surgery; or
Clindamycin 300 mg t.i.d. for 10 days, starting
2 days before the surgery, in case of allergy to
penicillins) to minimize the risk of infection. All




Frankfurt, Germany). Sinus were intervened
following the technique proposed by Galindo-
Moreno et al. (2007), using a bone scraper (Safe-
scraper
s
, Meta, Reggio Emilia, Italy) to harvest AB
from the lateral wall and expose the Schneiderian
membrane. Following membrane elevation, sinus
cavities were grafted with AB in combination
with ABB particles ranging from 250 to 1000mm
(Geistlich Bio-Oss
s
, Geistlich Pharma AG,
Wolhusen, Switzerland). Two different mixtures
were used, consisting of a 50% [AB] : 50% [ABB]
ratio (group 1) and a 20% [AB] : 80% [ABB] ratio
(group 2), reported previously as an ideal composite
proportion for maxillary sinus augmentation
procedures (Hallman et al. 2002b). As much graft
volume as necessary was used to meet the clinical
goal, to a maximum of 5 cm3 of material per sinus
cavity (Galindo-Moreno et al. 2008). After bone
grafting, an absorbable collagen membrane
(Geistlich Bio-Gide
s
, Geistlich Pharma AG) was
placed over the lateral aspect of the bony window.
Then, flaps were carefully approximated and
sutured with surgical silk 3/0 (Laboratorio Aragó,
Barcelona, Spain), attempting primary closure.
After a healing period of 6 months, a 3 mm
internal, 4 mm external diameter trephine was
used to harvest bone core biopsies from the
alveolar crest where implants were prosthetically
planned. Implants (Osseospeedt, Astra Tech,
Mölndal, Sweden) were placed in a submerged
approach. Dental implants were delivered only if
primary stability was attained (32 N/cm2 of in-
sertion torque). If implant primary stabilization
could not be achieved during implant placement,
the standard of care was applied: Either place-
ment of a larger (wider, longer, or both) implant
in order to achieve stability or abort implant
placement at that time, grafting the area (Geis-
tlich Bio-Oss
s
, Geistlich Pharma AG), and allow
further healing for an additional period of time
(at least 3 months).
Radiographic evaluation
Standardized digital panoramic X-rays (Kodak
ACR-2000, Eastman Kodak Company, Rochester,
NY, USA) were obtained at the time of implant
placement and 24 months after functional loading
in all cases.
A masked examiner (M. P.-M.) measured the
distance from the alveolar crest to the most apical
part of the graft, using specialized software (Dent-
A-View V 1.0, DigiDent, DIT, Nesher, Israel).
Histological and histomorphometrical analyses
Immediately after harvesting, bone core biopsies
were fixed in 10% buffered formalin for 24 h.
Then, samples were decalcified (Decalcifier I
s
,
Surgipath Europe Ltd, Peterborough, UK) contain-
ing formaldehyde (10% w/v), formic acid (8% w/
v), and methanol (1% w/v) for 420 days, and
embedded in paraffin. Bone biopsies were de-
waxed, hydrated, and sectioned ( 4mm) along
the central axis of the core. Sections were pro-
cessed for hematoxylin-eosin (H-E), teriodic acid
Schiff, Masson trichrome, and Goldner trichrome
staining. A millimeter scale in the eyepiece of a
microscope (BH2, Olympus Optical Company
Ltd, Tokyo, Japan) with a  40 objective was
used to count osteoblasts, osteoclasts, and osteo-
cytes per mm2. The results were expressed as
the mean number of positive cells per mm2.
Bone histomorphometric analyses were performed
semi-automatically using Masson trichrome-
stained sections. Ten randomized images per sam-
ple were captured with a microscope equipped
with a  10 objective and a digital camera
(DP70, Olympus Optical Company Ltd), con-
nected to a computer containing specialized soft-
ware to perform histomorphometric analysis
(ImageJ, NIH, Bethesda, MD, USA, http://rsb.info.
nih.gov/ij/). Vital bone, remaining ABB particle,
and non-mineralized tissue proportions were
quantified separately. The results were expressed
as percentages. Bone formation was assessed as a
function of the number of osteoid lines in the
total core biopsies length.
Immunohistochemical analysis
Decalcified and paraffin-embedded sections were
dewaxed, hydrated, and heat treated in 1 mM
EDTA buffer for antigenic unmasking in a PT
module (Thermo Fisher Scientific, Fremont, CA,
USA) at 951C during 20 min. Sections were
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incubated for 60 min at room temperature with
prediluted Osteopontin (OPN), and BMP-4 poly-
clonal antibodies to identify cellular and inter-
stitial expression, and prediluted monoclonal
antibodies CD56 [Clone 56C04/123A8] to iden-
tify osteoblastic cells, tartrate-resistant acid phos-
phatase (TRAP-1) [Clone 26E5] to identify
osteoclast cells and CD68 [Clone KP1] to identify
monocytes/macrophages cells, and vimentin
[Clone V9] to identify mesenchymal cells (posi-
tive control). All antibodies were purchased from
the same company (Master Diagnóstica, Gran-
ada, Spain). Immunohistochemical analysis was
performed utilizing an automatic immunostainer
(Autostainer 480, Thermo Fisher Scientific)
using the polymer-peroxidase-based method, fol-
lowed by development with diaminobenzidine
(Master Diagnóstica). A millimeter scale in the
eyepiece of a microscope (BH2, Olympus Optical
Company Ltd) with a  40 objective was used to
count positive cells per mm2. Histological, his-
tomorphometrical, and immunohistochemical
analyses were conducted by an experienced,
masked examiner (F.O.).
Statistical analysis
Following the descriptive analysis, the w2 test (for
gender, smokers, alcohol consumption, and type
of edentulism), and the Mann–Whitney U-test
(for determining significant differences between
treatment groups) were applied; a P-valueo0.05
was considered to be statistically significant.
Statistical analyses were performed using statis-
tical analysis software (SPSS-Windows 15.0,
SPSS Inc., Chicago, IL, USA).
Results
Study population
A total of 28 subjects (18 males and 10 females),
with a mean age of 47.3  9.8 (ranging from 30
to 72 years), participated in the study. In our
series, 28.57% of the study population was
totally edentulous, 71.42% of the patients were
smokers and 7.14% were alcohol consumers.
Patients were randomly assigned to the two
groups (n¼14 each), in order to account for these
demographical features. Hence, no statistically
significant difference among groups existed at
baseline, as reflected in Table 1. No major com-
plication was recorded in any case. All patients
completed the study.
Radiographic findings
Analysis of the differences between measure-
ments demonstrated statistically significant in-
creased bone resorption in patients from group 2
(0.27  0.12 mm in group 1 vs. 0.43  0.7 mm
in group 2; P¼0.033 Mann–Whitney U-test).
Histological and histomorphometrical analyses
All biopsy samples presented similar dimensions,
ranging from 13 to 15 mm of length (Fig. 1).
Histomorphometric analysis of group 1 samples
revealed that the mean proportion of vital bone
was 36  9.44%, average proportion of non-
mineralized tissue was 44.8  13.51%, and
19.36  14.58% was the mean value for remain-
ing ABB particles. Mean numbers of osteoblasts
and osteoclasts found per mm2 were 160.11 
220.89 and 106.38  173.11, respectively. Inter-
estingly, mean osteocyte count per mm2 was
631.85  607.98. On the other hand, analysis
of samples obtained from group 2 revealed that
the mean proportion of vital bone was 37.38
17.46%, the mean percentage of non-mineralized
tissue content was 31.92  16.05%, and aver-
age proportion of remaining ABB particles was
30.75  18.51%. Mean numbers of osteoblasts
and osteoclasts found per mm2 were 75.27 
58.89 and 50.41  33.87, respectively. Mean
value after osteocyte count was 219.08 
103.26. No significant differences between
groups were observed in relation to vital bone,
and non-mineralized tissue (Table 2). While tis-
sue compartments values did not show statisti-
cally significant differences between both graft
mixtures, osteoid lines were significantly more
abundant in the composite with higher quantity
of vital bone (18.05  10.06 in group 1 vs.
9.01  7.53 in group 2; P¼0.023, Mann–Whit-
ney U-test) (Fig. 2). Similarly, group 1 samples
exhibited more cellular presence in all analyzed
parameters as compared with group 2 specimens











Age 49.1 43.3 P¼ 0.155n –
Gender (male/female) 9/5 9/5 0.769 0.144
Smoker (yes/no) 12/2 8/6 0.376 0.22
Alcohol consumer (yes/no) 1/13 1/13 0.671 0.001
Totally edentulous (yes/no) 3/11 4/10 0.922 0.022
nMann–Whitney U-test.
AB, autologous bone; ABB, anorganic bovine bone particles.
Fig. 1. Comparative trephine biopsies from maxillary sinus augmentation of group 1 (a), and group 2 (b). ABB, anorganic
bovine bone particles; TB, trabecular bone. Scale bar 400 mm (Masson trichrome).
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(Table 2). Nonetheless differences were statisti-
cally significant only regarding the number of
osteocytes per mm2 (P¼0.002, Mann–Whitney
U-test).
Immunohistochemical analysis
Interestingly, no statistically significant difference
between groups with regard to the expression of any
of the immunohistochemical markers tested in this
study (CD56, TRAP-1, CD68, and BMP-4) was
observed. Regarding TRAP-1 expression, we found
the presence of a higher number of osteoclasts per
mm2 (TRAP-1 positive) in group 2 samples
(86.58 61.81 vs. 109.96 62.38, P¼0.25).
Furthermore, a higher number of osteoclasts per
ABB particles as identified in samples from group 2
(1.52 1.5 vs. 2.59 1.5, P¼0.06) predomi-
nantly surrounding ABB particles (Fig. 3). CD68
expression in osteoclasts cells was similar in both
groups (Fig. 4). BMP-4 was expressed in some
osteocytes of vital bone (cortical and trabecular),
osteoclasts, and osteoblasts for both groups, but not
in all cases (Fig. 5). OPN was expressed in vital
bone (cortical and trabecular) and in the cement
lines between remaining ABB particles and vital
bone, particularly in samples from group 1, and
significant differences were observed among groups
(0.68 0.25 in group 1 vs. 0.1 0.31, in group 2;
P¼0.013, Mann–Whitney U-test). A clear OPN
expression was observed in osteocytes present in
vital bone in group 1 specimens (Fig. 6). On the
other hand, a robust expression of OPN- and
TRAP-1-positive cells was observed in the surface
of ABB particles in specimens from group 2 (Figs 3
and 6).
Discussion
One of the critical aspects of any bone grafting
procedure is the selection of the biomaterial,
considering the goal of the intervention, indivi-
dual patient features, anatomic location, defect
morphology, and the properties of the material
itself. ABB has been regarded as an excellent
biomaterial for sinus augmentation given its
osteoconductive properties (Hallman et al.
2002a), structural stability (Schlegel et al. 2003),
and long-term positive clinical response (Mayfield
et al. 2001). However, this biomaterial does not
have the capacity to interact with titanium to
promote osseointegration (Valentini et al. 1998;
Rosenlicht & Tarnow 1999). Theoretically, this
could imply that grafts containing elevated propor-
tions of ABB may not be adequate to achieve an
optimal bone-to-implant contact (Haas et al.
1998). Smiler et al. (1992) reported that bone
formation was faster using a composite graft of
ABB granules and AB than with the application of
ABB as a sole grafting material. In a different study,
Table 2. Comparison of morphometrical variables between groups







Vital bone (%) 36  9.44 37.38  17.46 0.114
ABB particles (%) 19.36  14.58 30.75  18.51 0.013
Non-mineralized tissue (%) 44.8  13.51 31.92  16.05 0.324
Osteoblast cells (mm2) 160.11  220.89 75.27  58.89 0.531
Osteoclast cells (mm2) 106.38  173.11 50.41  33.87 0.327
Osteocytes (mm2) 631.85  607.98 219.08  103.26 0.002
Osteoid lines 18.05  10.06 9.01  7.53 0.023
Values are expressed as mean  standard deviation.
nMann–Whitney U-test.
AB, autologous bone; ABB, anorganic bovine bone particles.
Fig. 2. Morphological features of composite maxillary sinus graft after 6 months. Note the numerous osteoid lines (arrows) in
group 1 (50% [AB] : 50% [ABB] ratio) (a) in comparison with group 2 (20% [AB] : 80% [ABB] ratio) (b). ABB, anorganic bovine
bone particles; TB, trabecular bone; n-MT, non-mineralized tissue (Masson trichrome  40).
Fig. 3. Identification of osteoclasts cells (arrows) locates principally around ABB particles by means of immunohistochemical
tartrate-resistant acid phosphatase (TRAP-1) expression. In group 1 (a), there are less than group 2 (b) osteoclasts cells per ABB
particle and per millimeter square. Note TRAP-1 deposit in resorption edge of ABB particles(asterisk). ABB, anorganic bovine
bone particles; TB, trabecular bone; n-MT, non-mineralized tissue (polymer-peroxidase-based method  100).
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Tadjoedin et al. (2003) compared different AB to
ABB ratios in a human model and indicated that
the final amount of vital bone formed during the
healing period correlated inversely with the propor-
tion of ABB particles present in the graft. However,
a limitation of these studies was the low number of
patients included. Thorwarth and colleagues eval-
uated graft maturation using either ABB alone or a
composite of ABB and AB (75% to 25%, respec-
tively) in an animal model. The addition of auto-
genous bone to ABB resulted in higher initial
proportion of vital bone. It was concluded that
25% AB was an adequate proportion to induce
increased bone formation(Thorwarth et al. 2006).
Interestingly, Hallman et al. (2002b) showed in a
human study that among using AB, ABB, and a
combination of them, the best results in terms of
bone-to-implant contact and vital bone area were
achieved when both biomaterials were combined
in a 20% [AB] : 80% [ABB] ratio.
The present study was conducted to determine
if the use of two different AB to ABB ratios
(50 : 50 or 20 : 80) may affect graft consolidation
and bone remodeling after sinus augmentation.
Bone core biopsies were harvested after a healing
period of 6 months, at the time of implant
placement, in order to investigate the character-
istics of these tissues. Analysis of the proportion
of newly formed vital bone in human histological
samples has been traditionally accepted as a valid
method to evaluate sinus augmentation out-
comes (Wallace et al. 1996). Other morphometrical
and immunohistochemical parameters (i.e. oss-
eous cells count, OPN and TRAP-1 expression)
have also proven to be useful in assessing the bone
remodeling response after the process of graft
maturation (Galindo-Moreno et al. 2010a). Hence,
vital bone, non-mineralized tissue, and remaining
ABB particles proportion, as well as the number of
osteoblasts, osteoclasts, osteocytes, osteoid lines,
and the expression of several molecular markers
were determined in our samples.
After histomorphometric analysis, similar mean
vital bone proportion was observed for both groups.
However, vital bone percentage was very slightly
higher in samples containing a higher ABB propor-
tion (36 9.44% vs. 37.38 17.46%). Our
findings are in accordance with the data reported
by Hallman et al. (2002b) (37.7 31.3% [100%
AB]; 39.9 8% [20% AB : 80% ABB]; 41.7 
26.6% [100% ABB]). This finding may be ex-
plained because ABB appear to act as a guidance
to osteogenic cells from pre-existing bone surfaces
of the sinus floor along the surface of the grafted
ABB particles (Tadjoedin et al. 2003). Neverthe-
less, cell populations were found to be quite
different in both graft mixtures. Osteoid lines
were more abundant in the composite graft
with higher quantity of AB. Likewise, more
cellularity was observed in samples obtained
from group 1 in comparison with specimens
from group 2. This included all the cellular
components analyzed (osteoblasts, osteoclasts,
and osteocytes), although the difference was
statistically significant only for the number of
osteocytes. Our results suggest that bone meta-
bolism may be more intense in grafts containing
higher baseline vital bone proportions, as indi-
cated by Smiler et al. (1992). This tissue response
can be attributed to the presence of AB, which
may act as a local source of cells and bone matrix
proteins with osteoinductive properties (Thor-
warth et al. 2006).
A remarkable finding in our study was the
distribution of OPN. OPN is involved in a variety
of biologic events, including cell-binding activity
(Milam et al. 1991) and bone angiogenesis
(Matusan-Ilijas et al. 2008). OPN is secreted
not only by cells of the osteoblastic lineage
(Zohar et al. 1997) but also by osteocytes (McKee
& Nanci 1995; Sodek et al. 1995). In our sam-
ples, OPN was expressed markedly in osteocytes
present in vital bone in specimens containing
more AB (group 1). It is important to remember
that a statistically significant difference in the
number of osteocytes was observed between
Fig. 4. CD68 expression in osteoclasts cells (arrows). (a) Group 1 [50 : 50 AB to ABB ratio] (nosteoblast cells) (polymer-
peroxidase-based method  200). (b) Group 2 [20 : 80 AB to ABB ratio] (polymer-peroxidase-based method  100). ABB,
anorganic bovine bone particles; TB, trabecular bone; n-MT, non-mineralized tissue.
Fig. 5. BMP-4 expression. (a) Positives osteoblasts (arrows), and osteoclasts (asterisk). (b) Positives osteocytes (arrows) in
cortical bone (polymer-peroxidase-based method  200).
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groups in favor of group 1 (P¼0.002, Mann–
Whitney U-test). Likewise, the mean number of
osteoid lines was twice as much in the group with
higher quantity of vital bone. Taking in considera-
tion this information and the critical role that
osteocytes play in orchestrating bone metabolism
(Bonewald 2006), this distinctive pattern of OPN
expression may indicate that osteocyte-derived
OPN may be utilized in the cement line for
osteoblast adhesion or to guide early calcification
events at this junction (Ganss et al. 1999).
Interestingly, a marked expression of OPN on
ABB particles was observed in samples from
group 2. This distribution of OPN throughout
the anorganic bone matrix may influence osteo-
clast activity during resorption and maturation of
woven bone (Sodek et al. 2000). There is strong
evidence supporting the role of OPN in the
formation (Yamate et al. 1997), migration
(Noda et al. 1998), attachment (Katayama et al.
1998), and regulation of the resorptive activity of
osteoclasts (Duong & Rodan 1999). Understand-
ing of the role of OPN as a regulator of bone
remodeling is a very interesting topic because the
mechanisms that govern the dual behavior of
OPN remain unclear, as this protein can regulate
bone resorptive or osteogenic processes.
TRAP-1 protein is a specific marker for osteo-
clastic cells activity. The presence of a higher
number of osteoclasts TRAP-1 positive per mm2
was observed in group 2 samples. Furthermore,
more osteoclasts per ABB particles were identi-
fied in samples from group 2 and predominantly
surrounding ABB particles (Fig. 3); however,
these differences were not statistically signifi-
cant. Regarding these findings, Tadjoedin et al.
(2003) related the presence of many TRAP-posi-
tive multinucleated cells against the ABB gran-
ules, which may suggest that ABB granules were
gradually degraded and resorbed by the activity of
osteoclasts. Interestingly, in our study, TRAP-1-
positive cell distribution showed a similar pattern
to OPN expression. Osteoclast migration and
attachment is determined by phosphorylated
OPN, and this biological event is regulated by
the endogenous TRAP-1 (Ek-Rylander & An-
dersson 2009). This finding confirms that OPN
not only plays a major role in osteoclast activa-
tion but also facilitates osteoclast migration as
suggested previously (Razzouk et al. 2002).
Similar patterns of OPN and TRAP-1 expres-
sion intra-groups but different patterns inter-
groups, may indicate that the proportion of ABB
directly influences the net resorption of this
xenogenic material. Owing to its scaffolding
properties and its low resorption index, ABB
may contribute significantly to prevent volume
loss in grafted areas. While some authors have
indicated that ABB particles barely undergo resorp-
tion (Mordenfeld et al. 2010), our results from this
and previous studies, as well as others reported by
authors (Perrotti et al. 2009), contradict this con-
cept. Results presented in this study show that the
higher initial quantity of ABB particles, the more
the OPN and TRAP-1 expression found in
the remaining particles. However, in spite of
comprising less cellularity, a greater number of
osteoclasts expressing TRAP-1 over these particles
(1.52 1.5 vs. 2.59 1.5, P¼0.06) were ob-
served in samples from group 2. Radiographic
findings support this concept, given the increased
average resorption observed in group 2.
Conclusions
AB to ABB ratio was found to influence bone
remodeling patterns and cell content following
sinus augmentation procedures. A similar propor-
tion of vital bone was found in specimens obtained
from both groups. However, more cellular activity
was observed in samples containing more AB.
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